Plain-English translation of NCT07579481 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This trial is testing whether vortioxetine, an antidepressant medication, can help treat people who experience both depression and migraines. Depression and migraines often occur together and can make each other worse, but this medication works differently than older antidepressants and may help with both conditions at the same time. Researchers believe the medication's unique action on brain chemistry could reduce both depressive symptoms and migraine frequency.
Many people suffer from both depression and migraines, and the two conditions are closely connected in the brain. While older antidepressants have been tried for this combination, they haven't been studied much or worked consistently—so researchers want to test whether this newer medication might be more effective for treating both conditions together.
You likely qualify if…
You likely don't qualify if…
You will take the medication (which you've just started) as prescribed while researchers monitor how well it works for both your depression and migraines. You'll likely have clinic visits where doctors will ask about your symptoms and how you're feeling, and may perform tests or questionnaires to measure changes in your mood and migraine frequency. The study involves about 31 participants total and will track how the medication affects both conditions over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy